Erratum: Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients

被引:0
|
作者
M Figus
M Nardi
P Piaggi
M Sartini
G Guidi
L Martini
S Lazzeri
机构
来源
Eye | 2014年 / 28卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Correction to: Eye (2014) 28, 422–429; doi:10.1038/eye.2013.304; published online 17 January 2014 Since the publication of the above article, it has been noted that the colour of the lines in Figure 1 were the wrong way round. The correct figure appears below. The authors apologise for this error.
引用
收藏
页码:506 / 506
相关论文
共 50 条
  • [41] A 12-Month Randomized Clinical Trial of 38% SDF vs. Restorative Treatment
    Cleary, J.
    Al-Hadidi, R.
    Scully, A.
    Yahn, W.
    Zaid, Z.
    Boynton, J. R.
    Eckert, G. J.
    Yanca, E.
    Fontana, M.
    JDR CLINICAL & TRANSLATIONAL RESEARCH, 2022, 7 (02) : 135 - 144
  • [42] A randomized clinical trial comparing three fixed combinations of bimatoprost with timolol in patients with open-angle glaucoma or ocular hypertension
    Mrukwa-Kominek, Ewa
    Misiuk-Hojlo, Marta
    Csutak, Adrienne
    Stalmans, Ingeborg
    Garhofer, Gerhard
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (05) : 775 - 783
  • [43] Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial
    Oddone, Francesco
    Rossetti, Luca
    Tanga, Lucia
    Berardo, Francesca
    Ferrazza, Manuela
    Michelessi, Manuele
    Roberti, Gloria
    Manni, Gianluca
    Centofanti, Marco
    PLOS ONE, 2015, 10 (10):
  • [45] Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
    Harvey B DuBiner
    Douglas A Hubatsch
    BMC Ophthalmology, 14
  • [46] Telerehabilitation Programme as a Maintenance Strategy for COPD Patients: A 12-Month Randomized Clinical Trial
    Galdiz, Juan B.
    Gomez, Alba
    Rodriguez, Diego
    Guell, Rosa
    Cebollero, Pilar
    Hueto, Javier
    Cejudo, Pilar
    Ortega, Francisco
    Sayago, Itxaso
    Chic, Susana
    Iscar, Marta
    Amado, Carlos
    Rodriguez Trigo, Gemma
    Cosio, Borja G.
    Bustamante, Victor
    Ignacio Pijoan, Jose
    ARCHIVOS DE BRONCONEUMOLOGIA, 2021, 57 (03): : 195 - 204
  • [47] Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study
    Ying Ying Chen
    Tsing-Hong Wang
    Catherine Liu
    Kwou-Yeung Wu
    Shin-Lin Chiu
    Susan Simonyi
    Da-Wen Lu
    BMC Ophthalmology, 16
  • [48] Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study
    Chen, Ying Ying
    Wang, Tsing-Hong
    Liu, Catherine
    Wu, Kwou-Yeung
    Chiu, Shin-Lin
    Simonyi, Susan
    Lu, Da-Wen
    BMC OPHTHALMOLOGY, 2016, 16
  • [49] Titanium vs ceramic single dental implants in the anterior maxilla: A 12-month randomized clinical trial
    Ruiz Henao, Paula Andrea
    Caneiro Queija, Leticia
    Mareque, Santiago
    Tasende Pereira, Almudena
    Linares Gonzalez, Antonio
    Blanco Carrion, Juan
    CLINICAL ORAL IMPLANTS RESEARCH, 2021, 32 (08) : 951 - 961
  • [50] Clinical features and in vivo confocal microscopy assessment in 12 patients with ocular cicatricial pemphigoid
    Qin Long
    Ya-Gang Zuo
    Xue Yang
    Ting-Ting Gao
    Jie Liu
    Ying Li
    International Journal of Ophthalmology, 2016, (05) : 730 - 737